The short version

Some study pages carry a link to the compound that trial administered. If you buy through one, MitoiX may earn a commission at no extra cost to you. That is the only way this site earns money. No advertiser has ever seen a page before it was published, and none can.

What a link here is allowed to be

One rule: a study page may link to what the trial actually gave participants, labelled as what was tested. That is a statement about the study, not advice to you.

  • No product is ranked, scored, or called the best one.
  • No dose, protocol, or regimen is suggested anywhere on this site.
  • No brand comparison. Where a trial used a specific branded material, the page says so because that is what the trial used — not as an endorsement of that brand.
  • Interventions available only on prescription carry no purchase link at all. Elamipretide, for example, is an approved medicine for a rare genetic disease and is never linked for purchase.
  • No price appears next to a retailer link. The build fails if one does.

What a link is never allowed to change

The evidence tier, the five-qualifier claim, the species and endpoint labelling, and the negative or null findings are set by the record and by the methodology — never by whether a compound can be bought. Several compounds covered here have thin or unflattering human evidence, and the pages say so while the link sits on the same page. If that ever stops being true, this page is the one that was violated.

Programmes

MitoiX participates in the Amazon Associates Programme. As an Amazon Associate, MitoiX earns from qualifying purchases. Any further programme will be named here before its first link is published.

What this does not change

MitoiX remains an educational reference. It does not diagnose, does not recommend treatment, and is not a substitute for a clinician — see the medical disclaimer. Nothing on this site should be read as a reason to take a supplement.